Citius Oncology (CTOR) Research Hub

Citius Oncology (CTOR) trades on NASDAQ, US in the Healthcare (Drug Manufacturers - General) sector. As of 2026-10-26, shares last closed at 0.5957 USD (+2.80%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.22, market cap 0.06B. This hub links to the full technical, earnings and options research available for CTOR.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Drug Manufacturers - General)
ExchangeNASDAQ, US
Last close0.5957 USD (+2.80%)
52-week range0.5188 USD – 1.16 USD
Trend regimeRange
14-day RSI18.3 (Oversold)
Trailing P/E-1.22
Market cap0.06B
Dividend yield0.00%
Next earnings2026-08-18

Available research for CTOR

Earnings

CTOR earnings date and last-quarter result: next report 2026-08-18, last quarter miss, P/E -1.22. Updated 2026-07-23.

Options: Covered Call

Covered Call on CTOR: how it works, illustrative setup around the real 0.5957 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on CTOR: how it works, illustrative setup around the real 0.5957 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on CTOR: how it works, illustrative setup around the real 0.5957 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

CTOR technical analysis: range, last 0.5957 USD, RSI 18.3, 52w range 0.5188 USD–1.16 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is CTOR in?

Citius Oncology (CTOR) is classified under Healthcare (Drug Manufacturers - General), listed on NASDAQ, US.

Is CTOR in an uptrend or downtrend?

As of 2026-10-26, CTOR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is CTOR's trailing P/E ratio?

CTOR's trailing P/E is -1.22, with a market cap of 0.06B. See the earnings research page for full valuation detail.

When does CTOR next report earnings?

CTOR is next scheduled to report earnings on 2026-08-18.